Executive Business Partner (Office of the CEO) — World Labs
San Francisco, California, United States; San Francisco
Passionate about precision medicine and advancing the healthcare industry?
Recent advancements in underlying technology have finally made it possible for AI to impact clinical care in a meaningful way. Tempus' proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time.
We are looking for a key contributor for IVD projects in the generation of design documents, reports, SOPs, and other documentation towards the development of diagnostic assays. The position involves applying experience in quality and regulatory documentation to support the molecular R&D group in drafting documentation for regulatory submissions. You will work closely with Technical and Development Scientists, technologists, as well as Quality and Regulatory professionals.
What you’ll do:
Qualifications:
Highly desirable:
#LI-DA1
CHI: $50,000-$65,000
The expected salary range may vary for other locations. Actual salary may vary based on qualifications and experience. Tempus offers a full range of benefits, which may include incentive compensation, restricted stock units, medical and other benefits depending on the position.
We are an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
Seen 13 hours ago.
Original posting on NEA portfolio's site ↗
Posting text belongs to the employer. Removal requests: contact us.
Nearby
Same employer first, then the same role elsewhere.
San Francisco, California, United States; San Francisco
Las Vegas, NV; United States of America
Akron, OH; United States of America; Akron Corporate, GoodLife Health Center
New York City; United States of America; Chicago
One job at a time
Pick the job you actually want and we write for it.